Brovana Sepracor Inc. - Treatment for Chronic Obstructive Pulmonary Disease
Brovana is a long-acting beta2-agonist for inhalation via a nebulizer, used for the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.Posted: October 2006
Related articles
- Sepracor's Arformoterol NDA Filed by FDA; Drug Candidate for Chronic Obstructive Pulmonary Disease Moves Into Formal Review - February 13, 2006
- Sepracor Announces Submission of Arformoterol NDA to FDA for Chronic Obstructive Pulmonary Disease - December 13, 2005
Brovana (arformoterol tartrate) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
